Effects of Repeated Central Administration of Endothelin Type A Receptor Antagonist on the Development of Neuropathic Pain in Rats

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2013 Sep 28

PMID 24073407

Citations 6

Authors

Lydia W Tai

Victor K L Hung

Wei Mei

Qiu Qiu

Sookja K Chung

C W Cheung

Affiliations

Soon will be listed here.

Abstract

Endothelin-1 (ET-1) predominates in the endothelin family effectively in vascular tone control, mitogenesis, and neuromodulation. Its receptors are widespread in the central nervous system (CNS) associated with endogenous pain control, suggesting an important role of ET-1 in central pain processing. This study aimed to evaluate the effect of central ET-1 on the development of neuropathic pain behaviour by repeated intrathecal administration of endothelin type A receptor (ETAR) antagonist (BQ-123) in a sciatic nerve ligation (SNL) animal model. BQ-123 was administered intrathecally to rats at dosages 15 μg, 20 μg, 25 μg, and 30 μg, daily for 3 days. Mechanical allodynia was assessed daily 30 minutes before/after injection, 1 hour after injection of BQ-123 from post-SNL day 4 to day 6, and once on day 7 (without BQ-123 administration) before rats were sacrificed. Increasing trends of mechanical threshold were observed, and they reached significance at all dosages on post-SNL day 7 (P < 0.05 at dosage 15 μg and P < 0.001 at dosages 20 μg, 25 μg, and 30 μg) in comparison to control group. BQ-123 at dosage 30 μg showed the most stable and significant mechanical threshold rise. Repeated central administration of BQ-123 alleviated mechanical allodynia after SNL. Our results provide insight into the therapeutic strategies, including timing, against neuropathic pain development with ETAR antagonist.

Citing Articles

Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice.

Huang P, Li L, Chen Y, Li Y, Zhu D, Cui J Open Life Sci. 2024; 19(1):20220872.

PMID: 38840892 PMC: 11151397. DOI: 10.1515/biol-2022-0872.

Sub-anaesthetic dose of propofol attenuates mechanical allodynia in chronic post-ischaemic pain regulation of PTEN/PI3K/IL-6 signalling.

Leung S, Meng F, Liu J, Liu A, Ng H, Cheung C Mol Pain. 2023; 19:17448069231185232.

PMID: 37314769 PMC: 10293517. DOI: 10.1177/17448069231185232.

CXCR4/CX43 Regulate Diabetic Neuropathic Pain via Intercellular Interactions between Activated Neurons and Dysfunctional Astrocytes during Late Phase of Diabetes in Rats and the Effects of Antioxidant N-Acetyl-L-Cysteine.

Zhu D, Fan T, Chen Y, Huo X, Li Y, Liu D Oxid Med Cell Longev. 2022; 2022:8547563.

PMID: 35799894 PMC: 9256426. DOI: 10.1155/2022/8547563.

Endothelin receptor type A is involved in the development of oxaliplatin-induced mechanical allodynia and cold allodynia acting through spinal and peripheral mechanisms in rats.

Matsuura K, Sakai A, Watanabe Y, Mikahara Y, Sakamoto A, Suzuki H Mol Pain. 2021; 17:17448069211058004.

PMID: 34894846 PMC: 8679041. DOI: 10.1177/17448069211058004.

Progressive Increase of Inflammatory CXCR4 and TNF-Alpha in the Dorsal Root Ganglia and Spinal Cord Maintains Peripheral and Central Sensitization to Diabetic Neuropathic Pain in Rats.

Zhu D, Fan T, Huo X, Cui J, Cheung C, Xia Z Mediators Inflamm. 2019; 2019:4856156.

PMID: 31001066 PMC: 6437743. DOI: 10.1155/2019/4856156.

References

Khodorova A, Richter J, Vasko M, Strichartz G . Early and late contributions of glutamate and CGRP to mechanical sensitization by endothelin-1. J Pain. 2009; 10(7):740-9. PMC: 2720062. DOI: 10.1016/j.jpain.2009.01.265. View

Smits H, van Kleef M, Joosten E . Spinal cord stimulation of dorsal columns in a rat model of neuropathic pain: evidence for a segmental spinal mechanism of pain relief. Pain. 2011; 153(1):177-183. DOI: 10.1016/j.pain.2011.10.015. View

Takahashi Y, Hasegawa-Moriyama M, Sakurai T, Inada E . The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development. Anesth Analg. 2011; 113(2):398-404. DOI: 10.1213/ANE.0b013e31821b220c. View

Khodorova A, Strichartz G . Contralateral paw sensitization following injection of endothelin-1: effects of local anesthetics differentiate peripheral and central processes. Neuroscience. 2009; 165(2):553-60. PMC: 2795047. DOI: 10.1016/j.neuroscience.2009.10.049. View

Giaid A, Gibson S, Herrero M, Gentleman S, Legon S, Yanagisawa M . Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry. 1991; 95(3):303-14. DOI: 10.1007/BF00266781. View

Piovezan A, DOrleans-Juste P, Souza G, Rae G . Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation. Br J Pharmacol. 2000; 129(5):961-8. PMC: 1571931. DOI: 10.1038/sj.bjp.0703154. View

Kurokawa K, Yamada H, Ochi J . Topographical distribution of neurons containing endothelin type A receptor in the rat brain. J Comp Neurol. 1998; 389(2):348-60. DOI: 10.1002/(sici)1096-9861(19971215)389:2<348::aid-cne11>3.0.co;2-h. View

Nirogi R, Goura V, Shanmuganathan D, Jayarajan P, Abraham R . Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats. J Pharmacol Toxicol Methods. 2012; 66(1):8-13. DOI: 10.1016/j.vascn.2012.04.006. View

Hasue F, Kuwaki T, Yamada H, Fukuda Y, Shimoyama M . Inhibitory actions of endothelin-1 on pain processing. J Cardiovasc Pharmacol. 2005; 44 Suppl 1:S318-20. DOI: 10.1097/01.fjc.0000166271.40044.0c. View

10.

Kuwahata H, Komatsu T, Katsuyama S, Corasaniti M, Bagetta G, Sakurada S . Peripherally injected linalool and bergamot essential oil attenuate mechanical allodynia via inhibiting spinal ERK phosphorylation. Pharmacol Biochem Behav. 2012; 103(4):735-41. DOI: 10.1016/j.pbb.2012.11.003. View

11.

Bennett G, Chung J, Honore M, Seltzer Z . Models of neuropathic pain in the rat. Curr Protoc Neurosci. 2008; Chapter 9:Unit 9.14. DOI: 10.1002/0471142301.ns0914s22. View

12.

Khodorova A, Montmayeur J, Strichartz G . Endothelin receptors and pain. J Pain. 2008; 10(1):4-28. PMC: 2630124. DOI: 10.1016/j.jpain.2008.09.009. View

13.

Pomonis J, Rogers S, Peters C, Ghilardi J, Mantyh P . Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J Neurosci. 2001; 21(3):999-1006. PMC: 6762331. View

14.

Berti-Mattera L, Gariepy C, Burke R, Hall A . Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes. Exp Neurol. 2006; 201(2):399-406. DOI: 10.1016/j.expneurol.2006.04.034. View

15.

da Cunha J, Rae G, Ferreira S, Cunha F . Endothelins induce ETB receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C. Eur J Pharmacol. 2004; 501(1-3):87-94. DOI: 10.1016/j.ejphar.2004.08.004. View

16.

Seltzer Z, Dubner R, Shir Y . A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990; 43(2):205-218. DOI: 10.1016/0304-3959(90)91074-S. View

17.

Nikolov R, Maslarova J, Semkova I, Moyanova S . Intracerebroventricular endothelin-1 (ET-1) produces Ca(2+)-mediated antinociception in mice. Methods Find Exp Clin Pharmacol. 1992; 14(3):229-33. View

18.

Storkson R, Kjorsvik A, Tjolsen A, Hole K . Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods. 1996; 65(2):167-72. DOI: 10.1016/0165-0270(95)00164-6. View

19.

Khodorova A, Navarro B, Jouaville L, Murphy J, Rice F, Mazurkiewicz J . Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat Med. 2003; 9(8):1055-61. DOI: 10.1038/nm885. View

20.

Jarvis M, Wessale J, Zhu C, Lynch J, Dayton B, Calzadilla S . ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur J Pharmacol. 2000; 388(1):29-35. DOI: 10.1016/s0014-2999(99)00865-1. View